Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast/Loratadine Combination in Seasonal Allergic Rhinitis
NCT00963599Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Sep 1999
- Primary completion
- Nov 1999
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of montelukast and loratadine in seasonal allergic rhinitis (SAR) (4 arms), sponsored by Organon & Co. Primary endpoint: Mean Change From Baseline in Daytime Nasal Symptoms Score at 2 weeks. Started Sep 1999; status: completed.
02
Drugs
montelukastloratadine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00963599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00963599.